Julie Feder compensation by year
Aura Biosciences Summary Compensation Table · all 4 fiscal years held| Component | FY2020 | FY2021 | FY2023 | FY2024 |
|---|---|---|---|---|
| Salary | $343,216 | $360,407 | $437,825 | $381,334 |
| Bonus | $113,249 | $0 | $0 | $0 |
| Stock awards | $0 | $367,500 | $496,275 | $553,884 |
| Option awards | $95,877 | $1,466,906 | $763,500 | $608,174 |
| Non-equity incentive | $0 | $145,042 | $166,374 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $0 | $455,003 |
| Total | $552,342 | $2,339,855 | $1,863,974 | $1,998,395 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aura Biosciences, Inc. DEF 14A filed April 24, 2025, accession 0000950170-25-058062, and prior-year filings.
How this page was built: the Aura Biosciences, Inc. filed document, accession 0000950170-25-058062. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2025.
Aura Biosciences’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Elisabet de los Pinos | President, Chief Executive Officer and Director | $3,604,339 |
| Conor Kilroy | Chief Legal Officer and Secretary | $2,022,190 |
| Julie Feder · this page | Former Chief Financial Officer | $1,998,395 |
| J. Jill Hopkins | Chief Medical Officer and President of Research and Development | $1,226,076 |
The full Aura Biosciences compensation record
free company briefThis page is one person within Aura Biosciences's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Aura Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.